The monoterpene indole alkaloid (MIA)
mitragynine has garnered
attention as a potential treatment for pain, opioid use disorder,
and opioid withdrawal because of its combined pharmacology at opioid
and adrenergic receptors in humans. This alkaloid is unique to Mitragyna speciosa (kratom), which accumulates over 50 MIAs
and oxindole alkaloids in its leaves. Quantification of 10 targeted
alkaloids from several tissue types and cultivars of M. speciosa revealed that mitragynine accumulation was highest
in leaves, followed by stipules and stems, but was absent, along with
other alkaloids, in roots. While mitragynine is the predominant alkaloid
in mature leaves, juvenile leaves accumulate higher amounts of corynantheidine
and speciociliatine. Interestingly, corynantheidine has an inverse
relationship with mitragynine accumulation throughout leaf development.
Characterization of various cultivars of M. speciosa indicated altered alkaloidal profiles ranging from undetectable
to high levels of mitragynine. DNA barcoding and phylogenetic analysis
using ribosomal ITS sequences revealed polymorphisms
leading M. speciosa cultivars having lower mitragynine
content to group with other mitragyna species, suggesting interspecific
hybridization events. Root transcriptome analysis of low- and high-mitragynine-producing
cultivars indicated significant differences in gene expression and
revealed allelic variation, further supporting that hybridization
events may have impacted the alkaloid profile of M. speciosa.